477 related articles for article (PubMed ID: 7760847)
21. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
Ram TG; Ethier SP
Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
[TBL] [Abstract][Full Text] [Related]
22. Mammary gland factor activated by prolactin on mammary epithelial cells and acute-phase response factor activated by interleukin-6 in liver cells share DNA binding and transactivation potential.
Standke GJ; Meier VS; Groner B
Mol Endocrinol; 1994 Apr; 8(4):469-77. PubMed ID: 7519723
[TBL] [Abstract][Full Text] [Related]
23. Estrogen receptor functional activity changes during differentiation of mammary epithelial cells.
Faulds MH; Olsen H; Helguero LA; Gustafsson JA; Haldosén LA
Mol Endocrinol; 2004 Feb; 18(2):412-21. PubMed ID: 14605098
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor binding protein (IGFBP)-5 is upregulated during both differentiation and apoptosis in primary cultures of mouse mammary epithelial cells.
Lochrie JD; Phillips K; Tonner E; Flint DJ; Allan GJ; Price NC; Beattie J
J Cell Physiol; 2006 May; 207(2):471-9. PubMed ID: 16419030
[TBL] [Abstract][Full Text] [Related]
25. ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes.
Marikovsky M; Lavi S; Pinkas-Kramarski R; Karunagaran D; Liu N; Wen D; Yarden Y
Oncogene; 1995 Apr; 10(7):1403-11. PubMed ID: 7731691
[TBL] [Abstract][Full Text] [Related]
26. Expression and transactivating functions of the bZIP transcription factor GADD153 in mammary epithelial cells.
Talukder AH; Wang RA; Kumar R
Oncogene; 2002 Jun; 21(27):4289-300. PubMed ID: 12082616
[TBL] [Abstract][Full Text] [Related]
27. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
Ethier SP; Langton BC; Dilts CA
Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
[TBL] [Abstract][Full Text] [Related]
28. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors.
Bacus SS; Gudkov AV; Zelnick CR; Chin D; Stern R; Stancovski I; Peles E; Ben-Baruch N; Farbstein H; Lupu R
Cancer Res; 1993 Nov; 53(21):5251-61. PubMed ID: 8106145
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
[TBL] [Abstract][Full Text] [Related]
30. Dominant negative Ras enhances lactogenic hormone-induced differentiation by blocking activation of the Raf-Mek-Erk signal transduction pathway.
Cerrito MG; Galbaugh T; Wang W; Chopp T; Salomon D; Cutler ML
J Cell Physiol; 2004 Nov; 201(2):244-58. PubMed ID: 15334659
[TBL] [Abstract][Full Text] [Related]
31. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.
Karunagaran D; Tzahar E; Beerli RR; Chen X; Graus-Porta D; Ratzkin BJ; Seger R; Hynes NE; Yarden Y
EMBO J; 1996 Jan; 15(2):254-64. PubMed ID: 8617201
[TBL] [Abstract][Full Text] [Related]
32. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
[TBL] [Abstract][Full Text] [Related]
33. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
Gallego MI; Binart N; Robinson GW; Okagaki R; Coschigano KT; Perry J; Kopchick JJ; Oka T; Kelly PA; Hennighausen L
Dev Biol; 2001 Jan; 229(1):163-75. PubMed ID: 11133161
[TBL] [Abstract][Full Text] [Related]
34. Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells.
Bacus SS; Yarden Y; Oren M; Chin DM; Lyass L; Zelnick CR; Kazarov A; Toyofuku W; Gray-Bablin J; Beerli RR; Hynes NE; Nikiforov M; Haffner R; Gudkov A; Keyomarsi K
Oncogene; 1996 Jun; 12(12):2535-47. PubMed ID: 8700512
[TBL] [Abstract][Full Text] [Related]
35. The nuclear factor YY1 participates in repression of the beta-casein gene promoter in mammary epithelial cells and is counteracted by mammary gland factor during lactogenic hormone induction.
Meier VS; Groner B
Mol Cell Biol; 1994 Jan; 14(1):128-37. PubMed ID: 8264581
[TBL] [Abstract][Full Text] [Related]
36. The activated mammary gland specific nuclear factor (MGF) enhances in vitro transcription of the beta-casein gene promoter.
Happ B; Groner B
J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):21-30. PubMed ID: 8274437
[TBL] [Abstract][Full Text] [Related]
37. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
Krane IM; Leder P
Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899
[TBL] [Abstract][Full Text] [Related]
38. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
Ram TG; Hosick HL; Ethier SP
J Cell Physiol; 2000 Jun; 183(3):301-13. PubMed ID: 10797304
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells.
Accornero P; Miretti S; Starvaggi Cucuzza L; Martignani E; Baratta M
J Mol Endocrinol; 2010 Feb; 44(2):115-25. PubMed ID: 19850646
[TBL] [Abstract][Full Text] [Related]
40. Hormonal control of IGF-binding protein (IGFBP)-5 and IGFBP-2 secretion during differentiation of the HC11 mouse mammary epithelial cell line.
Phillips K; Park MA; Quarrie LH; Boutinaud M; Lochrie JD; Flint DJ; Allan GJ; Beattie J
J Mol Endocrinol; 2003 Aug; 31(1):197-208. PubMed ID: 12914536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
